Dr. Martens (LON:DOCS) Trading Down 11.6% – Should You Sell?

Dr. Martens plc (LON:DOCS)’s share price traded down 11.6% during trading on Wednesday . The company traded as low as GBX 65 and last traded at GBX 66.90. 9,032,986 shares changed hands during trading, an increase of 342% from the average session volume of 2,043,681 shares. The stock had previously closed at GBX 75.65.

Wall Street Analyst Weigh In

DOCS has been the subject of a number of analyst reports. Peel Hunt restated a “buy” rating on shares of Dr. Martens in a research note on Thursday, November 20th. Berenberg Bank reissued a “buy” rating on shares of Dr. Martens in a research note on Tuesday. Two analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, Dr. Martens presently has an average rating of “Moderate Buy” and a consensus target price of GBX 6,000.

Dr. Martens Stock Performance

The company has a market cap of £653.88 million, a P/E ratio of 39.79, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The stock has a 50 day moving average price of GBX 75.76 and a two-hundred day moving average price of GBX 83.16. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27.

Dr. Martens (LON:DOCS) last released its quarterly earnings results on Thursday, November 20th. The company reported GBX (0.90) EPS for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. On average, research analysts predict that Dr. Martens plc will post 2.5809394 earnings per share for the current fiscal year.

Insider Buying and Selling at Dr. Martens

In related news, insider Robert Hanson purchased 96,000 shares of the business’s stock in a transaction that occurred on Friday, December 5th. The stock was acquired at an average cost of GBX 79 per share, for a total transaction of £75,840. Insiders have purchased 97,130 shares of company stock valued at $7,673,816 in the last three months. 2.79% of the stock is currently owned by insiders.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over
60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and
wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the
1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and
accessories.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.